| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Seth Love | |
| J Scott Miners | |||
| P2860 | cites work | Brain infarction and the clinical expression of Alzheimer disease. The Nun Study | Q42435324 |
| Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. | Q42914740 | ||
| Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. | Q43243198 | ||
| Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein | Q44027019 | ||
| Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan | Q44350219 | ||
| High prevalence of neurovascular instability in neurodegenerative dementias. | Q44812547 | ||
| Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy | Q44822600 | ||
| Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging | Q24600644 | ||
| Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease | Q24682442 | ||
| Lacunar infarction and small vessel disease: pathology and pathophysiology | Q26824326 | ||
| Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele | Q27331411 | ||
| APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis | Q28145941 | ||
| Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme | Q28216644 | ||
| Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia | Q28346149 | ||
| Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans | Q28741472 | ||
| Pericytes regulate the blood-brain barrier | Q29615840 | ||
| Neurovascular regulation in the normal brain and in Alzheimer's disease | Q29619659 | ||
| Arterial stiffness and β-amyloid progression in nondemented elderly adults. | Q30409084 | ||
| Atrial fibrillation and risk of dementia: a prospective cohort study | Q30505985 | ||
| Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease | Q30557788 | ||
| Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity | Q30581493 | ||
| APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis | Q30655480 | ||
| Ischemic brain injury in cerebral amyloid angiopathy | Q30945201 | ||
| Vascular pathologies and cognition in a population-based cohort of elderly people | Q30975914 | ||
| Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions | Q30976985 | ||
| Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center | Q30982265 | ||
| Pathways of fluid drainage from the brain--morphological aspects and immunological significance in rat and man | Q30985026 | ||
| Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity | Q31017305 | ||
| Cerebral amyloid angiopathy in the elderly | Q70688721 | ||
| Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy | Q72007219 | ||
| Spontaneous cerebral haemorrhage from cerebral amyloid angiopathy | Q72384772 | ||
| Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model | Q73337645 | ||
| Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria | Q73550740 | ||
| Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy | Q74496715 | ||
| Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein | Q77781796 | ||
| Bosentan therapy for pulmonary arterial hypertension | Q77801473 | ||
| Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy | Q83275279 | ||
| White matter hypoperfusion and damage in dementia: post-mortem assessment | Q41674220 | ||
| Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. | Q41840991 | ||
| Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. | Q42132599 | ||
| Increased beta-secretase activity and expression in rats following transient cerebral ischemia | Q44878523 | ||
| Mechanisms of soluble beta-amyloid impairment of endothelial function | Q45023573 | ||
| Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein | Q45048594 | ||
| Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease | Q46175385 | ||
| Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. | Q46384417 | ||
| Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes | Q46640803 | ||
| Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. | Q46675546 | ||
| Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension | Q46709828 | ||
| Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral | Q46802143 | ||
| Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study. | Q47342966 | ||
| APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein | Q47860548 | ||
| Atherosclerosis is not implicated in association of APOE epsilon4 with AD. | Q48161264 | ||
| Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-β from the mouse brain. | Q48161443 | ||
| Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease | Q48187646 | ||
| APOE and cerebral amyloid angiopathy in the elderly | Q48204397 | ||
| Cerebral amyloid angiopathy in the aged | Q48223066 | ||
| Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia | Q48325111 | ||
| Bradykinin release and inactivation in brain of rats submitted to an experimental model of Alzheimer's disease. | Q48400413 | ||
| The vascular factor in Alzheimer's disease: a study in Golgi technique and electron microscopy | Q48420632 | ||
| Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease | Q48425123 | ||
| Hemodynamic aspects of Alzheimer's disease | Q48426560 | ||
| Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. | Q48429976 | ||
| Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme | Q48446299 | ||
| White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity | Q48471565 | ||
| Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia | Q48472027 | ||
| Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes | Q48483145 | ||
| Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease | Q48523607 | ||
| Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells | Q48564523 | ||
| The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). | Q48586177 | ||
| Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain | Q48590310 | ||
| Two types of sporadic cerebral amyloid angiopathy. | Q48661743 | ||
| Contributors to white matter damage in the frontal lobe in Alzheimer's disease | Q48700189 | ||
| Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage | Q48717237 | ||
| Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease | Q48811929 | ||
| Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease | Q48863175 | ||
| Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease | Q48875047 | ||
| The region 1-11 of Alzheimer amyloid-beta is critical for activation of contact-kinin system. | Q49058556 | ||
| Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study | Q49079099 | ||
| Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients | Q49226587 | ||
| Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy | Q49409019 | ||
| Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. | Q50644235 | ||
| Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease. | Q50703088 | ||
| Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. | Q50742360 | ||
| Dynamic cerebral autoregulation and tissue oxygenation in amnestic mild cognitive impairment. | Q50855822 | ||
| Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. | Q50972617 | ||
| Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's disease. | Q51031098 | ||
| Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. | Q51803993 | ||
| Association between subcortical vascular disease on CT and neuropathological findings. | Q51939212 | ||
| Clinicopathologic studies of primary cerebral amyloid angiopathy. | Q52107574 | ||
| Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic Antibodies. | Q52147644 | ||
| Assessment of activation of the plasma kallikrein-kinin system in frontal and temporal cortex in Alzheimer's disease and vascular dementia. | Q52605099 | ||
| The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. | Q53229521 | ||
| Vascular and metabolic reserve in Alzheimer's disease. | Q53236042 | ||
| Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. | Q53237896 | ||
| Increase of white matter string vessels in Alzheimer's disease. | Q53263944 | ||
| The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide. | Q53268032 | ||
| Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. | Q53281587 | ||
| Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. | Q53342942 | ||
| Pre-clinical diagnosis of Alzheimer disease combining platelet amyloid precursor protein ratio and rCBF spect analysis. | Q53371647 | ||
| Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study | Q57782154 | ||
| Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy | Q58477361 | ||
| High frequency of apolipoprotein E ?2 Allele in hemorrhage due to cerebral amyloid angiopathy | Q59691932 | ||
| High Prevalence of Orthostatic Hypotension in Mild Dementia | Q61903164 | ||
| A beta-peptides enhance vasoconstriction in cerebral circulation | Q31030422 | ||
| Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment | Q32016712 | ||
| Neurocardiovascular instability in cognitive impairment and dementia. | Q33148401 | ||
| Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions. | Q33151494 | ||
| Amyloid beta-(1-40) stimulates cyclic GMP production via release of kinins in primary cultured endothelial cells | Q33179138 | ||
| Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy | Q33291163 | ||
| Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging | Q33402373 | ||
| Cerebral amyloid angiopathy in dementia and old age. | Q33622745 | ||
| Overlap between pathology of Alzheimer disease and vascular dementia | Q33803172 | ||
| Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease | Q33831242 | ||
| ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia | Q33832181 | ||
| Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease | Q33872703 | ||
| Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. | Q33874860 | ||
| Contribution of vascular pathology to the clinical expression of dementia | Q33926682 | ||
| Aggregation of vascular risk factors and risk of incident Alzheimer disease | Q33989502 | ||
| Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? | Q34002989 | ||
| Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele | Q34145373 | ||
| Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease | Q34277495 | ||
| CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury | Q34318048 | ||
| Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor | Q34449990 | ||
| Cardiovascular risk factors and future risk of Alzheimer's disease | Q34484531 | ||
| The overlap between vascular disease and Alzheimer's disease--lessons from pathology | Q34484708 | ||
| Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort | Q34538939 | ||
| Bosentan: a dual endothelin receptor antagonist | Q34707006 | ||
| Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy. | Q34828890 | ||
| Contribution of vascular risk factors to the progression in Alzheimer disease | Q35017596 | ||
| The renin-angiotensin-aldosterone system and Alzheimer s disease? | Q35154546 | ||
| Cortical localization of microbleeds in cerebral amyloid angiopathy: an ultra high-field 7T MRI study. | Q35282033 | ||
| Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping study | Q35610026 | ||
| Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease | Q35774045 | ||
| Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy | Q36128656 | ||
| Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence. | Q36163574 | ||
| Neuropathological assessment of the lesions of significance in vascular dementia | Q36317478 | ||
| Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review | Q36317679 | ||
| Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models | Q36448521 | ||
| Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease | Q36604545 | ||
| Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias | Q36623399 | ||
| Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes. | Q36635917 | ||
| Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid | Q36707976 | ||
| Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease | Q36773984 | ||
| Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy | Q36786388 | ||
| Current status of bosentan for treatment of pulmonary hypertension | Q37053389 | ||
| Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. | Q37118134 | ||
| Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease | Q37169574 | ||
| Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells | Q37219722 | ||
| Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta. | Q37257169 | ||
| Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease | Q37262851 | ||
| Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy | Q37265428 | ||
| Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy | Q37410685 | ||
| Angiotensins in Alzheimer's disease - friend or foe? | Q37606768 | ||
| Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia | Q37723412 | ||
| Endothelin receptor antagonists: potential in Alzheimer's disease | Q37824737 | ||
| The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis? | Q37983707 | ||
| Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease | Q38116974 | ||
| Midlife vascular risk factors and the risk of Alzheimer's disease: a systematic review and meta-analysis | Q38229556 | ||
| Renin Angiotensin aldosterone system inhibition in controlling dementia-related cognitive decline. | Q38245626 | ||
| Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling. | Q38461156 | ||
| Cardiovascular disease contributes to Alzheimer's disease: evidence from large-scale genome-wide association studies | Q38483442 | ||
| Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue | Q38751727 | ||
| Efficacy of the specific endothelin a receptor antagonist zibotentan (ZD4054) in colorectal cancer: a preclinical study | Q39145493 | ||
| Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β. | Q39397123 | ||
| Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. | Q39597830 | ||
| Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study | Q39714158 | ||
| The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha | Q39887019 | ||
| Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. | Q40038717 | ||
| Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes | Q40135781 | ||
| Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation | Q40170530 | ||
| Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation. | Q40589513 | ||
| Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme | Q40808050 | ||
| Amyloid β peptide-induced inhibition of endothelial nitric oxide production involves oxidative stress-mediated constitutive eNOS/HSP90 interaction and disruption of agonist-mediated Akt activation | Q40874555 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| cerebrovascular disease | Q3010352 | ||
| human ageing | Q332154 | ||
| Alzheimer's disease | Q11081 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 645-58 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Acta Neuropathologica | Q343168 |
| P1476 | title | Cerebrovascular disease in ageing and Alzheimer's disease | |
| P478 | volume | 131 |
| Q37673238 | A Mediterranean Diet to Improve Cardiovascular and Cognitive Health: Protocol for a Randomised Controlled Intervention Study |
| Q92921499 | A cortical microvascular structure in vascular dementia, Alzheimer's disease, frontotemporal lobar degeneration and nondemented controls: a sign of angiogenesis due to brain ischaemia? |
| Q47697118 | A population neuroscience approach to the study of cerebral small vessel disease in mid- and late-life: an Invited Review |
| Q91614776 | APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease |
| Q99608983 | Abnormal Homocysteine Metabolism: An Insight of Alzheimer's Disease from DNA Methylation |
| Q64060113 | Alzheimer's disease: risk factors and potentially protective measures |
| Q92916846 | Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes |
| Q47272117 | Analysis of the vasculature by immunohistochemistry in paraffin-embedded brains |
| Q38407177 | Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence |
| Q89828549 | Association of Dual Decline in Memory and Gait Speed With Risk for Dementia Among Adults Older Than 60 Years: A Multicohort Individual-Level Meta-analysis |
| Q58697672 | CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease |
| Q90107242 | CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology |
| Q26747527 | Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease |
| Q41542097 | Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine? |
| Q38639506 | Cerebral Artery Pulsatility is Associated with Cognitive Impairment and Predicts Dementia in Individuals with Subjective Memory Decline or Mild Cognitive Impairment |
| Q48164180 | Cerebral Aβ40 and systemic hypertension. |
| Q48663991 | Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease |
| Q53125875 | Cerebrovascular pathology: the dark side of neurodegeneration. |
| Q90374636 | Clinical Experience in Treatment of Alzheimer's Disease with Jiannao Yizhi Formula () and Routine Western Medicine |
| Q64229486 | Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis |
| Q41711189 | Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains. |
| Q60923222 | Deficiency of TLR4 ameliorates hypoperfusion-induced brain pathology |
| Q48034315 | Differential associations between systemic markers of disease and cortical thickness in healthy middle-aged and older adults |
| Q48328265 | Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease |
| Q39003857 | Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders |
| Q41451444 | Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease |
| Q48095967 | Does pathology of small venules contribute to cerebral microinfarcts and dementia? |
| Q90212917 | Endothelial-derived plasma exosome proteins in Alzheimer's disease angiopathy |
| Q57040576 | Endothelins in inflammatory neurological diseases |
| Q37374629 | Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice. |
| Q33774995 | Epidermal growth factor prevents APOE4-induced cognitive and cerebrovascular deficits in female mice. |
| Q39383177 | Epidermal growth factor prevents oligomeric amyloid-β induced angiogenesis deficits in vitro. |
| Q54974138 | Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology? |
| Q57211696 | Is Beta-Amyloid Accumulation a Cause or Consequence of Alzheimer's Disease? |
| Q92382299 | Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease |
| Q92920915 | Linking Molecular Pathways and Large-Scale Computational Modeling to Assess Candidate Disease Mechanisms and Pharmacodynamics in Alzheimer's Disease |
| Q47620920 | Local oxygen homeostasis during various neuronal network activity states in the mouse hippocampus |
| Q36411475 | Mitochondrion to endoplasmic reticulum apposition length in zebrafish embryo spinal progenitors is unchanged in response to perturbations associated with Alzheimer's disease |
| Q91781508 | Modifiable Risk Factors for Alzheimer's Disease |
| Q50101151 | N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease. |
| Q99711188 | NLRP3 Is Involved in the Maintenance of Cerebral Pericytes |
| Q96230570 | Network Localisation of White Matter Damage in Cerebral Small Vessel Disease |
| Q38663632 | Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies |
| Q41087339 | Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction |
| Q36124590 | Post-mortem assessment in vascular dementia: advances and aspirations |
| Q38621253 | Strategies for dementia prevention: latest evidence and implications |
| Q52347539 | The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment? |
| Q42152328 | The Multimerization State of the Amyloid-β42 Amyloid Peptide Governs its Interaction Network with the Extracellular Matrix |
| Q47257826 | The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease |
| Q40552948 | Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment |
| Q89211454 | Watershed microinfarct pathology and cognition in older persons |
Search more.